| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lysophospholipids | 18 | 2023 | 67 | 2.970 |
Why?
|
| Sphingosine | 16 | 2023 | 73 | 2.730 |
Why?
|
| Endothelial Cells | 20 | 2025 | 477 | 2.100 |
Why?
|
| Lung | 25 | 2025 | 1365 | 1.750 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 11 | 2020 | 63 | 1.450 |
Why?
|
| Amifostine | 3 | 2024 | 50 | 1.440 |
Why?
|
| Endothelium, Vascular | 8 | 2018 | 436 | 1.420 |
Why?
|
| Reactive Oxygen Species | 12 | 2024 | 502 | 1.400 |
Why?
|
| Signal Transduction | 23 | 2024 | 3500 | 1.330 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2021 | 199 | 1.180 |
Why?
|
| Acute Lung Injury | 6 | 2025 | 68 | 1.160 |
Why?
|
| Pseudopodia | 3 | 2018 | 36 | 1.140 |
Why?
|
| Paxillin | 2 | 2021 | 59 | 1.110 |
Why?
|
| Pseudomonas Infections | 3 | 2019 | 94 | 1.070 |
Why?
|
| Pneumonia | 5 | 2024 | 193 | 1.060 |
Why?
|
| Ventilator-Induced Lung Injury | 9 | 2023 | 33 | 1.040 |
Why?
|
| Capillary Permeability | 10 | 2015 | 131 | 1.030 |
Why?
|
| Mitochondrial Dynamics | 3 | 2024 | 59 | 1.030 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 5 | 2024 | 210 | 1.000 |
Why?
|
| Lipopolysaccharides | 8 | 2025 | 300 | 0.890 |
Why?
|
| Inflammation | 9 | 2025 | 1050 | 0.840 |
Why?
|
| Phospholipase D | 3 | 2020 | 13 | 0.810 |
Why?
|
| Blood-Air Barrier | 3 | 2020 | 6 | 0.800 |
Why?
|
| Cadherins | 4 | 2023 | 180 | 0.740 |
Why?
|
| Aldehyde-Lyases | 6 | 2021 | 14 | 0.700 |
Why?
|
| Sphingolipids | 2 | 2018 | 21 | 0.700 |
Why?
|
| Antigens, CD | 4 | 2020 | 476 | 0.680 |
Why?
|
| Mice | 37 | 2025 | 12239 | 0.670 |
Why?
|
| Receptors, Lysosphingolipid | 8 | 2023 | 38 | 0.670 |
Why?
|
| Lung Injury | 2 | 2019 | 59 | 0.650 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2020 | 6 | 0.640 |
Why?
|
| Cell Nucleus | 2 | 2021 | 602 | 0.610 |
Why?
|
| Animals | 48 | 2025 | 28047 | 0.600 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 555 | 0.600 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2016 | 86 | 0.580 |
Why?
|
| Phospholipids | 5 | 2012 | 107 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 19 | 2024 | 3432 | 0.570 |
Why?
|
| Cells, Cultured | 17 | 2017 | 2828 | 0.560 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 13 | 0.540 |
Why?
|
| Phosphorylation | 6 | 2024 | 1130 | 0.530 |
Why?
|
| Anion Transport Proteins | 2 | 2016 | 10 | 0.530 |
Why?
|
| Endothelium | 4 | 2012 | 59 | 0.530 |
Why?
|
| NADPH Oxidases | 3 | 2016 | 85 | 0.510 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 77 | 0.510 |
Why?
|
| Bleomycin | 5 | 2024 | 99 | 0.500 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2021 | 47 | 0.480 |
Why?
|
| Mitochondria | 5 | 2024 | 612 | 0.460 |
Why?
|
| Hyperoxia | 3 | 2021 | 36 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2015 | 30 | 0.440 |
Why?
|
| NADP | 1 | 2013 | 48 | 0.390 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 30 | 0.380 |
Why?
|
| Cell Movement | 1 | 2016 | 804 | 0.380 |
Why?
|
| Guanine Nucleotide Exchange Factors | 6 | 2010 | 75 | 0.370 |
Why?
|
| Aldehydes | 3 | 2021 | 21 | 0.360 |
Why?
|
| Humans | 50 | 2025 | 93613 | 0.360 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 59 | 0.350 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 443 | 0.330 |
Why?
|
| Bronchoalveolar Lavage Fluid | 6 | 2024 | 133 | 0.320 |
Why?
|
| Cell Cycle Proteins | 3 | 2020 | 409 | 0.320 |
Why?
|
| Cytoskeleton | 5 | 2024 | 198 | 0.300 |
Why?
|
| Adherens Junctions | 4 | 2020 | 34 | 0.280 |
Why?
|
| Radiation-Protective Agents | 1 | 2008 | 98 | 0.280 |
Why?
|
| Phosphatidylcholines | 6 | 2011 | 49 | 0.260 |
Why?
|
| Cell Line | 7 | 2021 | 2458 | 0.240 |
Why?
|
| Cytokines | 4 | 2019 | 863 | 0.240 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2024 | 86 | 0.240 |
Why?
|
| Endotoxins | 1 | 2025 | 36 | 0.220 |
Why?
|
| Placental Hormones | 1 | 2005 | 3 | 0.220 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2024 | 4 | 0.220 |
Why?
|
| Lactams, Macrocyclic | 1 | 2024 | 15 | 0.220 |
Why?
|
| Fibroblasts | 3 | 2024 | 752 | 0.210 |
Why?
|
| Benzoquinones | 1 | 2024 | 26 | 0.210 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2024 | 17 | 0.210 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 26 | 0.210 |
Why?
|
| Inflammasomes | 1 | 2024 | 31 | 0.210 |
Why?
|
| Thrombin | 4 | 2020 | 60 | 0.210 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2024 | 45 | 0.210 |
Why?
|
| rho-Associated Kinases | 2 | 2024 | 161 | 0.210 |
Why?
|
| Histone Deacetylases | 3 | 2021 | 86 | 0.210 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2024 | 109 | 0.210 |
Why?
|
| Phenazines | 1 | 2024 | 7 | 0.210 |
Why?
|
| Gentian Violet | 1 | 2024 | 9 | 0.210 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2009 | 24 | 0.210 |
Why?
|
| Extracellular Vesicles | 1 | 2024 | 47 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2016 | 199 | 0.200 |
Why?
|
| Proteolysis | 1 | 2024 | 124 | 0.200 |
Why?
|
| Methanol | 2 | 2020 | 12 | 0.200 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2024 | 87 | 0.200 |
Why?
|
| Benzenesulfonates | 1 | 2024 | 49 | 0.200 |
Why?
|
| Methyltransferases | 1 | 2025 | 213 | 0.200 |
Why?
|
| Sirtuin 1 | 1 | 2024 | 36 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 91 | 0.200 |
Why?
|
| Mycoses | 1 | 2024 | 44 | 0.200 |
Why?
|
| Alveolar Epithelial Cells | 2 | 2020 | 18 | 0.200 |
Why?
|
| NAD | 1 | 2024 | 96 | 0.200 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2024 | 70 | 0.200 |
Why?
|
| Pyrrolidines | 2 | 2020 | 61 | 0.190 |
Why?
|
| Animals, Newborn | 2 | 2021 | 519 | 0.190 |
Why?
|
| Antioxidants | 3 | 2011 | 231 | 0.190 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 291 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 5 | 2015 | 254 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2021 | 701 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 319 | 0.190 |
Why?
|
| Genetic Therapy | 1 | 2005 | 365 | 0.190 |
Why?
|
| Vascular Diseases | 1 | 2023 | 118 | 0.180 |
Why?
|
| Mice, Knockout | 7 | 2020 | 2122 | 0.180 |
Why?
|
| Adenosine | 1 | 2025 | 274 | 0.180 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2021 | 4 | 0.180 |
Why?
|
| Multifunctional Enzymes | 1 | 2021 | 7 | 0.180 |
Why?
|
| DNA Primase | 1 | 2021 | 2 | 0.180 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2021 | 22 | 0.180 |
Why?
|
| Gene Deletion | 2 | 2020 | 351 | 0.180 |
Why?
|
| Male | 22 | 2025 | 44582 | 0.180 |
Why?
|
| Recombinational DNA Repair | 1 | 2021 | 10 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 304 | 0.180 |
Why?
|
| Pulmonary Artery | 5 | 2023 | 333 | 0.170 |
Why?
|
| BCG Vaccine | 1 | 2021 | 37 | 0.170 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 18 | 0.170 |
Why?
|
| Tyrosine | 1 | 2021 | 131 | 0.170 |
Why?
|
| Histones | 2 | 2021 | 361 | 0.170 |
Why?
|
| Microfilament Proteins | 2 | 2013 | 209 | 0.170 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 1980 | 0.170 |
Why?
|
| DNA, Single-Stranded | 1 | 2021 | 95 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 79 | 0.170 |
Why?
|
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2020 | 11 | 0.160 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 266 | 0.160 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2020 | 3 | 0.160 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2020 | 41 | 0.160 |
Why?
|
| Melanoma | 1 | 2005 | 495 | 0.160 |
Why?
|
| Airway Remodeling | 1 | 2020 | 10 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2020 | 35 | 0.160 |
Why?
|
| Apoptosis | 5 | 2021 | 1719 | 0.160 |
Why?
|
| BRCA2 Protein | 1 | 2021 | 173 | 0.160 |
Why?
|
| Plasmalogens | 1 | 2020 | 2 | 0.160 |
Why?
|
| Asthma | 2 | 2021 | 1039 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 364 | 0.160 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 98 | 0.160 |
Why?
|
| Coronavirus | 1 | 2020 | 20 | 0.160 |
Why?
|
| Iloprost | 2 | 2010 | 14 | 0.160 |
Why?
|
| RNA, Small Interfering | 8 | 2021 | 555 | 0.160 |
Why?
|
| Bibliometrics | 1 | 2020 | 45 | 0.150 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 369 | 0.150 |
Why?
|
| Regeneration | 1 | 2020 | 159 | 0.150 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 2493 | 0.140 |
Why?
|
| Cyclic AMP | 3 | 2024 | 276 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2005 | 940 | 0.140 |
Why?
|
| Simvastatin | 1 | 2018 | 106 | 0.140 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2009 | 111 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 306 | 0.140 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 40 | 0.130 |
Why?
|
| Chondrocytes | 1 | 2017 | 60 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 88 | 0.130 |
Why?
|
| Oxidation-Reduction | 5 | 2010 | 410 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 317 | 0.130 |
Why?
|
| Cortactin | 1 | 2016 | 11 | 0.130 |
Why?
|
| Membrane Proteins | 4 | 2023 | 1260 | 0.120 |
Why?
|
| Oxidative Stress | 3 | 2023 | 467 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2018 | 515 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2023 | 1735 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2020 | 434 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2021 | 1690 | 0.110 |
Why?
|
| Respiration, Artificial | 2 | 2009 | 423 | 0.110 |
Why?
|
| Catenins | 2 | 2012 | 11 | 0.110 |
Why?
|
| Tyrphostins | 1 | 2015 | 7 | 0.110 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 30 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 304 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2016 | 283 | 0.100 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2013 | 14 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2012 | 258 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1517 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 23 | 0.100 |
Why?
|
| rap1 GTP-Binding Proteins | 2 | 2012 | 10 | 0.100 |
Why?
|
| Tight Junctions | 2 | 2012 | 153 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2013 | 775 | 0.100 |
Why?
|
| NADPH Oxidase 2 | 1 | 2013 | 22 | 0.100 |
Why?
|
| p21-Activated Kinases | 2 | 2010 | 17 | 0.100 |
Why?
|
| NADPH Oxidase 4 | 1 | 2013 | 15 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 281 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2013 | 74 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 215 | 0.090 |
Why?
|
| Telomere-Binding Proteins | 1 | 2011 | 14 | 0.090 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 2 | 2010 | 17 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2010 | 276 | 0.080 |
Why?
|
| Immunoglobulins | 1 | 2011 | 122 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2024 | 696 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2010 | 38 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 174 | 0.080 |
Why?
|
| Sulfones | 2 | 2020 | 47 | 0.080 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2010 | 57 | 0.080 |
Why?
|
| Histone Deacetylase 2 | 2 | 2021 | 8 | 0.070 |
Why?
|
| Histone Deacetylase 1 | 2 | 2021 | 16 | 0.070 |
Why?
|
| Caveolin 1 | 1 | 2009 | 24 | 0.070 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 52 | 0.070 |
Why?
|
| Receptors, LDL | 1 | 2009 | 54 | 0.070 |
Why?
|
| Acetylation | 2 | 2021 | 149 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2009 | 306 | 0.070 |
Why?
|
| DNA Damage | 2 | 2021 | 389 | 0.070 |
Why?
|
| Female | 7 | 2021 | 48781 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2010 | 443 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2005 | 379 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2007 | 71 | 0.060 |
Why?
|
| Epoprostenol | 1 | 2007 | 46 | 0.060 |
Why?
|
| Fibronectins | 2 | 2020 | 100 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2013 | 47 | 0.060 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2005 | 24 | 0.060 |
Why?
|
| trans-Golgi Network | 1 | 2024 | 15 | 0.050 |
Why?
|
| Retroviridae | 1 | 2005 | 73 | 0.050 |
Why?
|
| Transgenes | 1 | 2005 | 171 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 154 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2024 | 62 | 0.050 |
Why?
|
| Methylation | 1 | 2025 | 288 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 578 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 528 | 0.050 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 3 | 2009 | 7 | 0.050 |
Why?
|
| ADAM10 Protein | 1 | 2023 | 8 | 0.050 |
Why?
|
| Nanostructures | 1 | 2024 | 89 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 204 | 0.050 |
Why?
|
| Electric Impedance | 3 | 2009 | 115 | 0.050 |
Why?
|
| Cell Communication | 1 | 2024 | 216 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 371 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2019 | 884 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2005 | 422 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1610 | 0.050 |
Why?
|
| Vascular Remodeling | 1 | 2023 | 21 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 193 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2023 | 98 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2003 | 92 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 438 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2024 | 157 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 885 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1584 | 0.050 |
Why?
|
| Cell Survival | 2 | 2021 | 1003 | 0.050 |
Why?
|
| Stem Cells | 1 | 2024 | 386 | 0.050 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2012 | 70 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 96 | 0.040 |
Why?
|
| Acyltransferases | 1 | 2021 | 52 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 385 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 88 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2021 | 89 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 347 | 0.040 |
Why?
|
| DNA Replication | 1 | 2021 | 168 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2020 | 57 | 0.040 |
Why?
|
| Klebsiella Infections | 1 | 2020 | 32 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 140 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 517 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2020 | 57 | 0.040 |
Why?
|
| Plasmids | 1 | 2020 | 272 | 0.040 |
Why?
|
| RNA Interference | 2 | 2013 | 379 | 0.040 |
Why?
|
| Internationality | 1 | 2020 | 78 | 0.040 |
Why?
|
| China | 1 | 2020 | 264 | 0.040 |
Why?
|
| Cell Count | 1 | 2020 | 195 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 79 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 712 | 0.040 |
Why?
|
| Random Allocation | 2 | 2010 | 307 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 1924 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 303 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 153 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2025 | 2020 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2756 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 273 | 0.040 |
Why?
|
| Oligopeptides | 2 | 2010 | 190 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 523 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 302 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 200 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 1322 | 0.030 |
Why?
|
| beta Catenin | 2 | 2011 | 265 | 0.030 |
Why?
|
| Actins | 2 | 2013 | 467 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 648 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2016 | 42 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 1339 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 68 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 133 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 538 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1304 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1233 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1790 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 315 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 476 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 672 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 878 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3833 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 55 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2545 | 0.020 |
Why?
|
| Mutation | 1 | 2024 | 4266 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 200 | 0.020 |
Why?
|
| Allergens | 1 | 2013 | 189 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2013 | 261 | 0.020 |
Why?
|
| Collagen | 1 | 2013 | 300 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 435 | 0.020 |
Why?
|
| Occludin | 1 | 2011 | 66 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 27 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 416 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 102 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 122 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 5406 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 273 | 0.020 |
Why?
|
| Child | 1 | 2021 | 7362 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 108 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2009 | 13 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 292 | 0.020 |
Why?
|
| Rats | 2 | 2008 | 4042 | 0.020 |
Why?
|
| Microtubules | 1 | 2010 | 134 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 177 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 248 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2010 | 479 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2008 | 37 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 408 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2007 | 10 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2007 | 18 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 2006 | 4 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 688 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 143 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 21 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 423 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 222 | 0.010 |
Why?
|
| CD146 Antigen | 1 | 2005 | 4 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 2005 | 8 | 0.010 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 16 | 0.010 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 47 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2005 | 40 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 433 | 0.010 |
Why?
|
| Carbon Tetrachloride | 1 | 2003 | 6 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 2003 | 26 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2003 | 24 | 0.010 |
Why?
|
| Catalase | 1 | 2003 | 46 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2003 | 45 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 72 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 71 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 115 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 164 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2003 | 155 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 364 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 878 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 639 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1913 | 0.010 |
Why?
|
| Liver | 1 | 2003 | 1207 | 0.010 |
Why?
|
| Oxygen | 1 | 2003 | 768 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 755 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 3058 | 0.010 |
Why?
|
| Obesity | 1 | 2005 | 1019 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 20472 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 27623 | 0.010 |
Why?
|